Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent of $400.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent · last filed 2013-02-28
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for the quarter ending 2012-12-31 was -$600.00K, a 250.00% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for the quarter ending 2012-09-30 was $300.00K.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for the quarter ending 2012-06-30 was -$800.00K.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for the quarter ending 2012-03-31 was $1.50M, a 37.50% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2012 was $400.00K.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2011 was -$2.30M, a 151.11% decline from fiscal 2010.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2010 was $4.50M, a 8.16% decline from fiscal 2009.
- Edwards Lifesciences Corporation other comprehensive income (loss), available-for-sale securities adjustment, before tax, portion attributable to parent for fiscal 2009 was $4.90M.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$300.00K derived: sum of 2 quarters · filed 2013-02-28 | -$1.10M derived: sum of 3 quarters · filed 2013-02-28 | $400.00K 10-K · filed 2013-02-28 |
| 2012-09-30 | $300.00K 10-Q · filed 2012-11-07 | -$500.00K derived: sum of 2 quarters · filed 2012-11-07 | $1.00M 10-Q · filed 2012-11-07 | $1.40M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-06-30 | -$800.00K 10-Q · filed 2012-08-07 | $700.00K 10-Q · filed 2012-08-07 | $1.10M derived: sum of 3 quarters · filed 2013-02-28 | -$1.10M derived: sum of 4 quarters · filed 2013-02-28 |
| 2012-03-31 | $1.50M 10-Q · filed 2012-05-09 | $1.90M derived: sum of 2 quarters · filed 2013-02-28 | -$300.00K derived: sum of 3 quarters · filed 2013-02-28 | -$3.20M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$1.80M derived: sum of 2 quarters · filed 2013-02-28 | -$4.70M derived: sum of 3 quarters · filed 2013-02-28 | -$2.30M 10-K · filed 2013-02-28 |
| 2011-09-30 | -$2.20M 10-Q · filed 2012-11-07 | -$5.10M derived: sum of 2 quarters · filed 2012-11-07 | -$2.70M 10-Q · filed 2012-11-07 | |
| 2011-06-30 | -$2.90M 10-Q · filed 2012-08-07 | -$500.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $2.40M 10-Q · filed 2012-05-09 | |||
| 2010-12-31 | $4.50M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $4.90M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |